Cargando…

Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients

PURPOSE: Drug Reaction With Eosinophilia and Systemic Symptom (DRESS), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN) are acute hypersensitivity reactions with the potential to reduce the quality of life of exposed individuals. This study aims to determine the quality of life o...

Descripción completa

Detalles Bibliográficos
Autores principales: Perwitasari, Dyah Aryani, Febriana, Sri Awalia, Tristiana, Ratna Septi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894792/
https://www.ncbi.nlm.nih.gov/pubmed/33623374
http://dx.doi.org/10.2147/PPA.S285256
_version_ 1783653300763099136
author Perwitasari, Dyah Aryani
Febriana, Sri Awalia
Tristiana, Ratna Septi
author_facet Perwitasari, Dyah Aryani
Febriana, Sri Awalia
Tristiana, Ratna Septi
author_sort Perwitasari, Dyah Aryani
collection PubMed
description PURPOSE: Drug Reaction With Eosinophilia and Systemic Symptom (DRESS), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN) are acute hypersensitivity reactions with the potential to reduce the quality of life of exposed individuals. This study aims to determine the quality of life of patients suffering from DRESS, SJS, SJS/TEN. PATIENTS AND METHODS: A cross-sectional approach was used to get the quality of life data from DRESS, SJS, and/or TEN patients at Dr. Sardjito general hospital, Yogyakarta. The utility index and VAS score differences of EQ-5D-5L were analyzed based on the diagnosis. RESULTS: We recruited 58 patients. Most of the patients were female (63%). The mean value of utility index was 0.61, 0.08 and 0.03 for DRESS, SJS and SJS/TEN patients, respectively (p value <0.01). Furthermore, the mean of VAS score was 73.36, 57.93 and 50.00 for DRESS, SJS and SJS/TEN patients, respectively (p value <0.01). CONCLUSION: In general, the quality of life of DRESS patients is better than the quality of life of SJS and/or TEN patients.
format Online
Article
Text
id pubmed-7894792
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78947922021-02-22 Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients Perwitasari, Dyah Aryani Febriana, Sri Awalia Tristiana, Ratna Septi Patient Prefer Adherence Original Research PURPOSE: Drug Reaction With Eosinophilia and Systemic Symptom (DRESS), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN) are acute hypersensitivity reactions with the potential to reduce the quality of life of exposed individuals. This study aims to determine the quality of life of patients suffering from DRESS, SJS, SJS/TEN. PATIENTS AND METHODS: A cross-sectional approach was used to get the quality of life data from DRESS, SJS, and/or TEN patients at Dr. Sardjito general hospital, Yogyakarta. The utility index and VAS score differences of EQ-5D-5L were analyzed based on the diagnosis. RESULTS: We recruited 58 patients. Most of the patients were female (63%). The mean value of utility index was 0.61, 0.08 and 0.03 for DRESS, SJS and SJS/TEN patients, respectively (p value <0.01). Furthermore, the mean of VAS score was 73.36, 57.93 and 50.00 for DRESS, SJS and SJS/TEN patients, respectively (p value <0.01). CONCLUSION: In general, the quality of life of DRESS patients is better than the quality of life of SJS and/or TEN patients. Dove 2021-02-15 /pmc/articles/PMC7894792/ /pubmed/33623374 http://dx.doi.org/10.2147/PPA.S285256 Text en © 2021 Perwitasari et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Perwitasari, Dyah Aryani
Febriana, Sri Awalia
Tristiana, Ratna Septi
Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
title Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
title_full Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
title_fullStr Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
title_full_unstemmed Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
title_short Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
title_sort quality of life of drug reaction with eosinophilia and systemic symptom (dress) and stevens-johnson syndrome (sjs) and/or toxic epidermal necrolysis (ten) patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894792/
https://www.ncbi.nlm.nih.gov/pubmed/33623374
http://dx.doi.org/10.2147/PPA.S285256
work_keys_str_mv AT perwitasaridyaharyani qualityoflifeofdrugreactionwitheosinophiliaandsystemicsymptomdressandstevensjohnsonsyndromesjsandortoxicepidermalnecrolysistenpatients
AT febrianasriawalia qualityoflifeofdrugreactionwitheosinophiliaandsystemicsymptomdressandstevensjohnsonsyndromesjsandortoxicepidermalnecrolysistenpatients
AT tristianaratnasepti qualityoflifeofdrugreactionwitheosinophiliaandsystemicsymptomdressandstevensjohnsonsyndromesjsandortoxicepidermalnecrolysistenpatients